Literature DB >> 19732750

Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene.

Akihiko Ishimura1, Minoru Terashima, Hiroshi Kimura, Keiko Akagi, Yutaka Suzuki, Sumio Sugano, Takeshi Suzuki.   

Abstract

Jmjd2c is a candidate oncogene that encodes histone lysine demethylase. In this study, we discovered that over-expression of Jmjd2c increased the expression of Mdm2 oncogene dependent on its demethylase activity, which led to the reduction of p53 tumor suppressor gene product in the cells. A chromatin immunoprecipitation assay showed that Jmjd2c was recruited to the P2 promoter region of Mdm2 gene resulting in demethylation of histone H3 lysine 9, as typically found in actively transcribed genes. Furthermore, siRNA-mediated knockdown of Jmjd2c caused the reduction of Mdm2 expression in the cells. These results indicate that Mdm2 oncogene is a downstream target of Jmjd2c and may play an important role in Jmjd2c-mediated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732750     DOI: 10.1016/j.bbrc.2009.08.155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

2.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

3.  KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.

Authors:  Zanabazar Enkhbaatar; Minoru Terashima; Dulamsuren Oktyabri; Shoichiro Tange; Akihiko Ishimura; Seiji Yano; Takeshi Suzuki
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

4.  Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Andreana Holowatyj; Xiu-E Xu; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Shao-Hong Wang; En-Min Li; Zeng-Quan Yang; Li-Yan Xu
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

5.  Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.

Authors:  Luma Dayane de Carvalho Filiú-Braga; Teresa Raquel Tavares Serejo; Antonio Roberto Lucena-Araujo; Francisco Assis Rocha Neves; Juliana Lott de Carvalho; Eduardo Magalhaes Rego; Felipe Saldanha-Araujo
Journal:  Med Oncol       Date:  2018-11-13       Impact factor: 3.064

6.  Identification and functional analysis of 9p24 amplified genes in human breast cancer.

Authors:  J Wu; S Liu; G Liu; A Dombkowski; J Abrams; R Martin-Trevino; M S Wicha; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

7.  The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development.

Authors:  Marianne Terndrup Pedersen; Karl Agger; Anne Laugesen; Jens V Johansen; Paul A C Cloos; Jesper Christensen; Kristian Helin
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

8.  Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.

Authors:  Inbal Ipenberg; Noga Guttmann-Raviv; Hanan P Khoury; Ilana Kupershmit; Nabieh Ayoub
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

9.  Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Authors:  Tae-Dong Kim; James R Fuchs; Eric Schwartz; Dalia Abdelhamid; Jonathan Etter; William L Berry; Chenglong Li; Michael A Ihnat; Pui-Kai Li; Ralf Janknecht
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

Review 10.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.